[1]
|
Therapy for Gastric Cancer with Peritoneal Metastasis Using Injectable Albumin Hydrogel Hybridized with Paclitaxel-Loaded Red Blood Cell Membrane Nanoparticles
ACS Biomaterials Science & Engineering,
2019
DOI:10.1021/acsbiomaterials.8b01557
|
|
|
[2]
|
Therapy for Gastric Cancer with Peritoneal Metastasis Using Injectable Albumin Hydrogel Hybridized with Paclitaxel-Loaded Red Blood Cell Membrane Nanoparticles
ACS Biomaterials Science & Engineering,
2019
DOI:10.1021/acsbiomaterials.8b01557
|
|
|
[3]
|
Adjuvant intraperitoneal chemotherapy for the treatment of gastric cancer at risk for peritoneal carcinomatosis: A systematic review
Journal of Surgical Oncology,
2017
DOI:10.1002/jso.24476
|
|
|
[4]
|
Adjuvant intraperitoneal chemotherapy for the treatment of gastric cancer at risk for peritoneal carcinomatosis: A systematic review
Journal of Surgical Oncology,
2017
DOI:10.1002/jso.24476
|
|
|
[5]
|
Establishing a xenograft mouse model of peritoneal dissemination of gastric cancer with organ invasion and fibrosis
BMC Cancer,
2017
DOI:10.1186/s12885-016-2991-9
|
|
|
[6]
|
Low-dose paclitaxel suppresses the induction of M2 macrophages in gastric cancer
Oncology Reports,
2017
DOI:10.3892/or.2017.5586
|
|
|
[7]
|
Adjuvant intraperitoneal chemotherapy for the treatment of colorectal cancer at risk for peritoneal carcinomatosis: a systematic review
International Journal of Hyperthermia,
2017
DOI:10.1080/02656736.2017.1401742
|
|
|
[8]
|
Protein-bound polysaccharide K suppresses tumor fibrosis in gastric cancer by inhibiting the TGF-β signaling pathway
Oncology Reports,
2015
DOI:10.3892/or.2014.3636
|
|
|
[9]
|
The Angiotensin II type 1 receptor blocker candesartan suppresses proliferation and fibrosis in gastric cancer
Cancer Letters,
2014
DOI:10.1016/j.canlet.2014.09.019
|
|
|